IPEC Europe sets supply chain security high on the agenda
LONDON, April 10, 2008-The usual perception of counterfeit medicines is an illegal copy of a finished medicine slipped into the supply chain by illicit manufacturers. But the reality is far more complex and individual components, including excipients, are also vulnerable to counterfeiting.
That is one reason why the European arm of the International Pharmaceutical Excipients Council (IPEC Europe) made the issue of counterfeited, diverted and/or mislabeled medicines a cornerstone of their recently-held 2008 seminar.
10 April 2008